News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)

Cooperation for faster drug discovery

The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...

Read more …

Fighting Chronic Diseases and Cancer

For the study, which has now been published in the journal Antioxidants, the team led by experimental physicist Florian Grüner of the University of Hamburg ...

Read more …

Evotec: Collaboration with Bristol Myers Squibb

Evotec SE announced that its collaboration with Bristol Myers Squibb has been expanded to include a new cell type, triggering a payment of $ 9.0 ...

Read more …

Evotec & Takeda: strategic RNA alliance

Evotec SE today announced that the Company has entered into a multi-RNA target alliance with Takeda Pharmaceutical Company Limited (“Takeda”) with the goal to discover ...

Read more …

Indivumed Announces Expansion

Indivumed GmbH (“Indivumed”) announced today the founding of Ix Therapeutics GmbH (“Ix Therapeutics”), a joint venture with Xlife Sciences AG (“Xlife Sciences”), which marks Indivumed’s ...

Read more …
© Foundation for Biomedical Research and Innovation (FBRI)

FBRI and Fraunhofer IME: Research Agreement with Japanese company

As part of their long term co-operation the Foundation for Biomedical Research and Innovation at Kobe (FBRI), the Fraunhofer ...

Read more …

Just - Evotec produce antibody products against COVID-19

Evotec SE today announced that the U.S. Department of Defense (“DOD”) awarded its Seattle-based subsidiary, Just – Evotec Biologics, Inc. a contract valued up to ...

Read more …
Humane von iPSC abgeleitete Neurone mit MAP2-Färbung (rot). Zellkerne sind mit Hoechst-Farbstoff markiert (blau).
© Fraunhofer IME | Undine Haferkamp

BMBF funds MS-project with 1.2 million Euro

The University Medical Center Hamburg-Eppendorf (UKE) and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME want to pave the way for new therapies ...

Read more …

Just-Evotec Biologics partners with ABL against HIV

Evotec SE today announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into an agreement with Advanced BioScience Laboratories, Inc. (“ABL”), a ...

Read more …